00:06:49 Vickie Danaher And then either semaglutide products for obesity, so either the oral tablets or the injectable lead to about 26 or 27 pounds more weight loss than placebo
A head-to-head review of clinical studies determined that among available GLP-1 RAs, there were A1C reductions from 0.78% to 1.9%
Those trends cut against the super-sized model that has long underpinned fast-food profitability, where customers barely paused before "supersizing" fries for under a dollar or choosing a burger with an extra patty
They can protect lean body mass and micronutrient status during weight loss (which is often rapid with GLP-1s)
But here's the catch: retatrutide isn't approved yet
In addition to peripheral effects, certain hepatokines, such as FGF-21, SELENOP, Fetuin-A, ANGPTL3, MANF, Adropin, ApoJ, and SHBG, exhibit direct or indirect effects on the CNS and represent promising therapeutic targets for AD (Figure.2)